These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30582674)

  • 1. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clot contraction on clot degradation: A mathematical and experimental approach.
    Risman RA; Abdelhamid A; Weisel JW; Bannish BE; Tutwiler V
    Biophys J; 2022 Sep; 121(17):3271-3285. PubMed ID: 35927957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing interactions of red blood cells and contracting fibrin platelet clots.
    Sun Y; Le H; Lam WA; Alexeev A
    Biophys J; 2023 Nov; 122(21):4123-4134. PubMed ID: 37598293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.
    Weisel JW; Litvinov RI
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):161-80. PubMed ID: 18673231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy.
    Nastałek M; Wojas-Pelc A; Undas A
    J Thromb Thrombolysis; 2010 Aug; 30(2):121-6. PubMed ID: 20419337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot retraction facilitates clot lysis.
    Carroll RC; Gerrard JM; Gilliam JM
    Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin.
    Cines DB; Lebedeva T; Nagaswami C; Hayes V; Massefski W; Litvinov RI; Rauova L; Lowery TJ; Weisel JW
    Blood; 2014 Mar; 123(10):1596-603. PubMed ID: 24335500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis: an illustrated review.
    Risman RA; Kirby NC; Bannish BE; Hudson NE; Tutwiler V
    Res Pract Thromb Haemost; 2023 Feb; 7(2):100081. PubMed ID: 36942151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.
    Lai BF; Zou Y; Brooks DE; Kizhakkedathu JN
    Biomaterials; 2010 Aug; 31(22):5749-58. PubMed ID: 20435346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.
    Tutwiler V; Litvinov RI; Lozhkin AP; Peshkova AD; Lebedeva T; Ataullakhanov FI; Spiller KL; Cines DB; Weisel JW
    Blood; 2016 Jan; 127(1):149-59. PubMed ID: 26603837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathrombus Fibrin Attenuates Spatial Sorting of Phosphatidylserine Exposing Platelets during Clotting Under Flow.
    Trigani KT; Diamond SL
    Thromb Haemost; 2021 Jan; 121(1):46-57. PubMed ID: 32961573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.